Zobrazeno 1 - 8
of 8
pro vyhledávání: '"J R, Paisey"'
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): Boston Scientific Background The relationships between baseline tissue local impedance (LI), contact force (CF), atrial fibrosis and atrial rhythm are uninvest
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): Boston Scientific Background 3D electroanatomical mapping systems demonstrate atrial scar by recording local tissue voltages as a surrogate. Increased scar has
Autor:
A Briosa E Gala, A J Sharp, D Schramm, W Ries, M T B Pope, M Leo, J R Paisey, N Curzen, T R Betts
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Introduction The 2020 ESC AF management guideline states that a 30-second single-lead electrocardiogram (sl-ECG) can be used to diagnose atrial fibrillation, but advises caution as most validati
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): Boston Scientific Background Common cut-offs for dense scar and ‘low-voltage areas’ on atrial 3D electroanatomical mapping are 0.05mV and 0.50mV respective
Autor:
A. Kyriacou, M. Earley, J. M. Morgan, A. Sohaib, P. Kanagaratnam, A. W. Chow, F. S. Schlindwein, W. Davies, B. Unsworth, R. W. Bowers, M. D. Lowe, D. Janks, E. R. Behr, V. Mulholland, S. Singarayar, P. Roberts, P. Kirchhof, F. Goromonzi, G. A. Ng, S. M. Sopher, R. Kamdar, T. Berriman, C. Krusche, V. Baker, K. M. Holzem, R. Leube, M. Dhaliwal, D. Abrams, P. B. Lim, S. Jamil-Copley, S. H. Chin, A. Sandilands, R. Schilling, B. Sandler, J. Mayet, P. D. Lambiase, F. S. Ng, K. E. Brack, A. L. Wit, A. Martin, M. Lovell, J. R. Paisey, I. Diab, M. Papadakis, W. Bai, L. Richmond, S. Sharma, J. Ghosh, I. R. Efimov, C. Mfuko, G. J. Mellor, M. Koa-Wing, A. Yue, S. Hayat, H. Raju, J. de Bono, A. C. Koppel, O. R. Segal, G. Lee, S. Gomes, M. A. El-Harasis, R. Hunter, T. Y. Yue, E. Vloumidi, M. N. Sheppard, L. Fortmuller, C. M. N. Terracciano, M. Dhinoja, S. Sporton, J. Winter, T. P. Almeida, E. Dupont, R. A. Chowdhury, J. McCready, N. Peters, K. H. Chan, S. V. de Noronha, S. Ahsan, A. Keech, W. Ullah, D. O'Regan, A. Ng, F. Syeda, D. Rueckert, B. Ariff, N. Masca, V. Sawhney, M. McGuire, R. J. Schilling, Z. Whinnett, N. S. Peters, E. Duncan, G. S. Chu, S. Armstrong, N. Qureshi, P. D. Brown, R. N. Balasubramaniam, L. Fabritz, J. Paisey, A. J. Sandilands
Publikováno v:
Europace. 15:iv4-iv8
Autor:
L. Fabritz, L. Fortmuller, E. Vloumidi, T. Y. Yue, F. Syeda, P. Kirchhof, R. Leube, C. Krusche, S. H. Chin, J. Winter, K. E. Brack, G. A. Ng, F. S. Ng, K. M. Holzem, A. C. Koppel, D. Janks, A. L. Wit, N. S. Peters, I. R. Efimov, R. A. Chowdhury, M. A. El-Harasis, E. Dupont, C. M. N. Terracciano, G. J. Mellor, H. Raju, S. V. de Noronha, M. Papadakis, S. Sharma, E. R. Behr, M. N. Sheppard, S. Jamil-Copley, W. Bai, B. Ariff, P. B. Lim, M. Koa-Wing, A. Kyriacou, S. Hayat, A. Sohaib, N. Qureshi, B. Sandler, D. O'Regan, Z. Whinnett, W. Davies, D. Rueckert, P. Kanagaratnam, N. Peters, P. D. Lambiase, A. W. Chow, M. D. Lowe, O. R. Segal, S. Ahsan, J. de Bono, M. Dhaliwal, C. Mfuko, A. Ng, A. Sandilands, J. Paisey, P. Roberts, J. M. Morgan, J. McCready, A. Yue, W. Ullah, R. Hunter, M. Lovell, M. Dhinoja, S. Sporton, M. Earley, R. Schilling, J. Ghosh, A. Martin, A. Keech, K. H. Chan, S. Gomes, S. Singarayar, M. McGuire, G. Lee, T. Berriman, I. Diab, R. Kamdar, L. Richmond, V. Baker, F. Goromonzi, V. Sawhney, E. Duncan, B. Unsworth, J. Mayet, D. Abrams, R. J. Schilling, R. W. Bowers, V. Mulholland, R. N. Balasubramaniam, J. R. Paisey, S. M. Sopher, G. S. Chu, S. Armstrong, N. Masca, T. P. Almeida, P. D. Brown, A. J. Sandilands, F. S. Schlindwein
Publikováno v:
Europace. 15:iv9-iv13
Publikováno v:
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2(3)
Patients being considered for ICD therapy are a heterogeneous group.For the vast majority, who have significant left ventricular impairment, it has become common practice to assess their coronary artery anatomy as a surrogate for ischaemia and/or via
Publikováno v:
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. 8(1)
Animal studies have shown that defibrillation in coronary veins is more effective than in the right ventricle. We aimed to assess the feasibility of placing defibrillation electrodes in the middle cardiac vein (MCV) in man and its impact on defibrill